Study Stopped
The study was terminated due to insufficient staffing, which impacted the ability to continue subject enrollment and study operations.
Impact of Interactive ICU Diary on Psychological Distress
Effects of Technology-Driven, Interactive Intensive Care Unit Diary on Psychological Distress in Patients Requiring Intensive Care: A Randomized Controlled Trial
1 other identifier
interventional
56
1 country
1
Brief Summary
This study investigates the effectiveness of a technology-driven, interactive ICU diary in reducing psychological distress, specifically anxiety, depression, and stress, in ICU patients. A single-blind, parallel-group randomized controlled trial will include 56 conscious ICU patients. The primary outcome measures are the Depression, Anxiety, and Stress Scale-21 (DASS-21) and the EuroQol instrument (EQ-5D), assessed at ICU admission, discharge, and one month post-discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedStudy Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedAugust 14, 2025
July 1, 2024
8 months
July 10, 2024
August 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Psychological Distress Levels (DASS-21)
The primary outcome will be the psychological distress levels measured by the Depression, Anxiety, and Stress Scale-21 (DASS-21). This scale assesses anxiety, depression, and stress in ICU patients through 21 items, each rated from 0 ("Did not apply to me at all - Never") to 3 ("Applied to me very much, or most of the time - Almost always"). The total score for each subscale (DASS-21-Depression, DASS-21-Anxiety, and DASS-21-Stress) ranges from 0 to 21, with higher scores indicating greater emotional distress. The cutoff scores for DASS-21-Depression, DASS-21-Anxiety, and DASS-21-Stress are \>9, \>7, and \>14, respectively.
7 days after admission and one month post-discharge.
Secondary Outcomes (1)
Quality of Life (EQ-5D)
7 days after admission and one month post-discharge.
Study Arms (2)
Interactive ICU Diary Group
EXPERIMENTALPatients in this group will use a technology-driven, interactive ICU diary from the first day of ICU admission until discharge. Through the diary platform, patients can share their feelings and needs, while family members can send supportive messages, pictures, and videos. Healthcare providers will use the platform to connect with families and monitor patient conditions. The goal is to reduce psychological distress, specifically anxiety, depression, and stress, during the ICU stay.
routine care
NO INTERVENTIONPatients in this group will receive standard ICU care without the use of the interactive ICU diary.
Interventions
Through the diary platform, patients can share their feelings and needs, while family members can send supportive messages, pictures, and videos. Healthcare providers will use the platform to connect with families and monitor patient conditions.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Clear consciousness and able to communicate in Mandarin, Taiwanese, or Hakka
- Expected ICU stay of at least 72 hours
- Ability to operate a smart device and use social media applications
You may not qualify if:
- Presence of delirium before joining the study (Intensive Care Delirium Screening Checklist score ≥ 4)
- Physical, auditory, or visual impairments preventing the use of smart devices History of epilepsy, cognitive impairments (e.g., hepatic encephalopathy, dementia), or psychiatric disorders
- Richmond Agitation-Sedation Scale score not between +1 and -1 (indicating excessive sedation or agitation)
- Acute Physiology and Chronic Health Evaluation Score (APACHE-II) \> 25 within the first 24 hours of ICU admission (indicating \> 50% mortality rate)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei Medical University Hospital
Taipei, 110, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hsiao-Yean Chiu
Taipei Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 22, 2024
Study Start
September 1, 2024
Primary Completion
April 30, 2025
Study Completion
May 31, 2025
Last Updated
August 14, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share